| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |